LASERSCAN LSX EXCIMER LASER SYSTEM

Excimer Laser System

FDA Premarket Approval P980008

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the laserscan lsx excimer laser system. The device is indicated for myopic photorefractive keratectomy: for the reduction or elimination of myopia ranging from -1. 0 to less than -6. 0 diopters (d) with less than or equal to 1. 0 d of astigmatism; in patients with documentation of a stable manifest refraction (+-0. 5d) over the prior one year; and in patients who are 18 years of age or older.

DeviceLASERSCAN LSX EXCIMER LASER SYSTEM
Classification NameExcimer Laser System
Generic NameExcimer Laser System
ApplicantLASERSIGHT TECHNOLOGIES, INC.
Date Received1998-03-19
Decision Date1999-11-12
PMAP980008
SupplementS
Product CodeLZS
Docket Number00M-1231
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address LASERSIGHT TECHNOLOGIES, INC. 6903 University Blvd., winter Park, FL 32792
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P980008Original Filing
S012 2002-10-31 Real-time Process
S011
S010
S009 2001-10-26 Special (immediate Track)
S008 2001-10-05 Real-time Process
S007
S006
S005 2000-12-19 Panel Track
S004
S003 2000-07-20 Real-time Process
S002 2000-07-13 Normal 180 Day Track
S001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.